IRIS
GUIDOTTI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 854
NA - Nord America 591
AS - Asia 358
AF - Africa 12
OC - Oceania 5
SA - Sud America 1
Totale 1.821
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 590
SE - Svezia 528
SG - Singapore 205
CN - Cina 127
RU - Federazione Russa 123
IT - Italia 100
FI - Finlandia 29
DE - Germania 27
IE - Irlanda 16
GH - Ghana 12
IN - India 8
NL - Olanda 6
AU - Australia 5
ID - Indonesia 5
GB - Regno Unito 4
IR - Iran 4
AT - Austria 3
CH - Svizzera 3
FR - Francia 3
RO - Romania 3
TW - Taiwan 3
UA - Ucraina 3
PL - Polonia 2
DK - Danimarca 1
EC - Ecuador 1
JP - Giappone 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
PH - Filippine 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 1.821
Salva come PNG Salva come JPEG
Città #
Lawrence 142
Princeton 142
Singapore 124
Ashburn 120
Milan 46
Shanghai 40
Boardman 29
Helsinki 29
Moscow 17
Dublin 16
New York 16
Accra 12
Guangzhou 9
Los Angeles 9
Jiaxing 8
Pune 8
Rome 6
Shenzhen 6
Wuxi 5
Ancona 4
Beijing 4
Bloomington 4
Dallas 4
San Giustino Valdarno 4
Amsterdam 3
Bandung 3
Flero 3
Saint-Martin-d'Hères 3
Taizhou 3
Vernate 3
Vienna 3
Washington 3
Xi'an 3
Zhengzhou 3
Arezzo 2
Brisbane 2
Cernusco sul Naviglio 2
Chandler 2
Clusone 2
Frankfurt am Main 2
Freiburg im Breisgau 2
Genoa 2
Haining 2
Hanover 2
Irpin 2
Mainz 2
Padang 2
Santa Clara 2
Seattle 2
Taipei 2
Turin 2
Xiamen 2
Almaty 1
Andover 1
Bangkok 1
Borås 1
Bratislava 1
Buffalo 1
Chiaravalle 1
Chiari 1
Cornate 1
Davao City 1
Foshan 1
Friesland 1
Fuzhou 1
Gorle 1
Guayaquil 1
Hillsboro 1
Jiujiang 1
Liberty Lake 1
London 1
Lucca 1
Monza 1
Nagoya 1
Newcastle 1
Novara 1
Perth 1
Quanzhou 1
Riga 1
San Francisco 1
Segrate 1
Seoul 1
Shenyang 1
Shijiazhuang 1
Skopje 1
Sydney 1
Walsall 1
Wuhan 1
Zhuji 1
Zola Predosa 1
Zurich 1
Totale 909
Salva come PNG Salva come JPEG
Nome #
Immunobiology and pathogenesis of hepatitis B virus infection 57
Role of CCL2/MCP-1 in islet transplantation 41
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming 33
Inflammatory monocytes hinder antiviral B cell responses 25
Cyclic inhibitors of hepatitis B virus 25
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 23
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. 22
Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma 22
Immunosurveillance of the liver by intravascular effector CD8+ T cells 22
Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity 22
Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens 21
Extracellular HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV pathogenesis 21
Inhibitors of hepatitis B virus 21
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability 21
Arenaviral infection causes bleeding in mice due to reduced serotonin release from platelets 20
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators 20
Bone marrow as an alternative site for islet transplantation 20
Bone marrow as an alternative site for islet transplantation 20
Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus 20
Bisphosphonates Target B Cells to Enhance Humoral Immune Responses 20
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion 20
Breaking tolerance leads to autoantibody production but not autoimmune liver-disease in hepatitis-B virus envelope transgenic mice 19
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming 19
Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis 18
A global scientific strategy to cure hepatitis B 18
Tricyclic inhibitors of hepatitis B virus 18
Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier 17
A two hit model of CTL killing in vivo 17
Editorial overview: Viral pathogenesis 17
Altered helper T lymphocyte (HTL) function associated with chronic HBV infection and its role in response to therapeutic vaccination in humans 17
IFN gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment 17
Protective and Pathogenic T Cell Responses to Virus Infections 17
Modulation of Early Inflammatory Reactions to Promote Engraftment and Function of Transplanted Pancreatic Islets in Autoimmune Diabetes 17
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination 17
Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice 16
Kupffer cells reduce liver immunopathology 16
Platelets mediate cytotoxic T lymphocyte-induced liver damage 16
Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans 16
Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes 16
Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection 16
Immunological insights in the treatment of chronic hepatitis B 16
T helper-1 lymphocytes mediate liver disease in hepatitis B virus transgenic mice 15
Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site 15
Cytotoxic T-lymphocytes inhibit hepatitis-B virus gene-expression by a noncytolytic mechanism in transgenic mice 15
A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen 15
Activated intrahepatic antigen presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice 15
Oxalamido-substituted tricyclic inhibitors of hepatitis B virus 15
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy 14
HBV pathogenesis in animal models: Recent advances on the role of platelets 14
MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs 14
Cytokine-mediated control of viral infections 14
The COP9 signalosome is a repressor of replicative stress responses and polyploidization in the regenerating liver 14
Cytotoxic T-lymphocyte mediated regulation of hepatitis-B virus gene-expression in-vivo 13
Platelets mediate CTL-induced immunopathology in the liver 13
Pathogenesis of hepatitis B virus in transgenic mice 13
Cytotoxic T-lymphocytes can clear hepatitis-B virus from the hepatocyte without killing the cell 13
In vivo flow mapping in complex vessel networks by single image correlation 13
Effector CD8+T cell-derived interleukin-10 enhances acute liver immunopathology 13
Effector CD8 T cell trafficking within the liver 13
Host-virus interactions during malaria infection in hepatitis B virus transgenic mice 13
Microcirculation in the murine liver: a computational fluid dynamic model based on 3D reconstruction from in vivo microscopy 13
HBV Immunopathogenesis 13
Class-I restricted cytotoxic T-lymphocytes are directly cytopathic for their target-cells in-vivo 13
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice 12
Different intrahepatic cytoknie priles during acure HBV and HCV infection in the same chimpanzees 12
Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes 12
The optimization of helper T lymphocyte (HTL) function in vaccine development 12
On the role of platelets in the pathogenesis of viral hepatitis 12
CTL access to tissue antigen is restricted in-vivo 12
Mechanisms of class-I restricted immunopathology - a transgenic mouse model of fulminant-hepatitis 12
Platelets mediate clearance of lymphocytic choriomeningitis virus infection preventing lethal hemorrhage 12
Eukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species-dependent megakaryocyte maturation 12
Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice 12
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 12
Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study 12
Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus 11
Nkx2-5+/Islet1+ mesenchymal progenitors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity 11
Hepatitis-B virus nucleocapsid particles do not cross the hepatocyte nuclear-membrane in transgenic mice 11
Analysis of a successful immune response against HBV 11
Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis 11
Reduced severity of liver ischemia/reperfusion injury following hepatic resection in humans is associated with enhanced intrahepatic expression of Th2 cytokines 11
Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice 11
Hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice 11
The hepatitis B virus X protein transactivates viral core gene expression in vivo 11
Natural killer T cell activation inhibits hepatitis B virus replication in vivo 11
The transgenic mouse model of hepatitis B virus infection 11
Mouse models of hepatitis B virus pathogenesis 11
Platelets mediate cytotoxic T lymphocyte-induced liver damage 11
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses 10
Liver gene expression associated with the inhibition of HBV replication or transcription 10
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus 10
High-level hepatitis-B virus-replication in transgenic mice 10
To kill or to cure: Options in host defense against viral infection 10
Pathogenetic and antiviral immune responses against hepatitis B virus 10
Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes 10
Hepatitis C virus core and E2 protein expression in transgenic mice 10
Interleukin-2 down-regulates hepatitis-B virus gene-expression in transgenic mice by a posttranscriptional mechanism 10
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes 10
Developing a cure for chronic hepatitis B requires a fresh approach 9
Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis 9
Totale 1.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 1 1 0 0 0 0 0 0
2020/202116 0 1 0 3 2 3 5 0 0 2 0 0
2021/2022121 0 0 0 57 2 0 6 3 5 7 5 36
2022/2023846 302 200 62 2 13 118 21 78 31 1 4 14
2023/2024419 22 16 59 114 29 37 13 29 4 10 31 55
2024/2025437 264 20 15 59 79 0 0 0 0 0 0 0
Totale 1.929